3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
95
Phase NA
62
Phase 1/2
31
Phase 2
19
Phase EARLY_PHASE1
8
Phase 3
7
Phase 2/3
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
37
Genitourinary
2
Breast
2
Thoracic
1
Sarcoma
1
Other
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
88
Lung Neoplasms
70
Small Cell Lung Carcinoma
11
Pleural Effusion, Malignant
9
Melanoma
7
Ovarian Neoplasms
6
NSCLC
6
Pleural Effusion
5
Neoplasms
5
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Mesothelioma
4
Lung Diseases
4
Carcinoma, Renal Cell
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thoracic Neoplasms
3
Pneumothorax
3
Pleural Neoplasms
3
Pancreatic Neoplasms
3
Non-Squamous Non-Small Cell Lung Cancer
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Brain Neoplasms
3
Venous Thromboembolism
2
Urinary Bladder Neoplasms
2
Interventions
Sevoflurane
1
Propofol
1
Isoflurane
1
Desflurane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Colonic Neoplasms
×
Thoracic
×
Clear all
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled